Premium
Use of genomic markers to risk stratify men with prostate cancer
Author(s) -
Davis John W.
Publication year - 2015
Publication title -
trends in urology and men's health
Language(s) - English
Resource type - Journals
eISSN - 2044-3749
pISSN - 2044-3730
DOI - 10.1002/tre.461
Subject(s) - prostate cancer , medicine , cancer , risk assessment , prostate , oncology , computer science , computer security
New genomic biomarkers are being developed to refine the risk for men with prostate cancer, but for healthcare professionals to believe in them, they must be both valid and of clinical utility. John Davis reviews three of these biomarkers, providing advice on how to interpret results and make decisions.